Company Profiles

driven by the PitchBook Platform

Orlucent

Description

Developer of diagnostic technology for melanoma. The company is engaged in development of real time diagnostic that will assist dermatologists identify melanoma by providing biological information of melanoma activity.

2008

Founded

PRIVATE

Status

Grant

Latest Deal Type

$258k

Total Amount Raised

2

Investors

Description

Developer of diagnostic technology for melanoma. The company is engaged in development of real time diagnostic that will assist dermatologists identify melanoma by providing biological information of melanoma activity.

Website:

www.orlucent.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Discovery Tools (Healthcare)

Other Industries

Other Healthcare

Primary Office

750 South California Avenue Palo Alto, CA 94306United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Orlucent's full profile, request a free trial.

    Orlucent Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Orlucent Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Orlucent Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    BIRD FoundationOther000 0000000 0000
    Emergent Medical PartnersVenture CapitalMinority000 0000000 0000
    BIRD Foundation Other
    Emergent Medical Partners Venture Capital

    Orlucent Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Cathy Shachaf Ph.DFounder, President and CSO
    Cathy Shachaf Ph.D Founder, President and CSO
    Request full access to PitchBook